Aytu BioPharma, Inc. is a pharmaceutical company dedicated to commercializing novel therapeutics. Its Rx Segment focuses on prescription products primarily distributed through third-party wholesalers, featuring two main portfolios: ADHD and Pediatric. Key products include Adzenys XR-ODT and Cotempla XR-ODT, both extended-release orally disintegrating tablets for ADHD treatment. Additionally, the company offers Karbinal ER, an antihistamine for allergic conditions, and the fluoride-based vitamin lines Poly-Vi-Flor and Tri-Vi-Flor, designed for infants and children with fluoride deficiencies. We show 35 historical shares outstanding datapoints in our AYTU shares outstanding history coverage, used to compute AYTU market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AYTU market cap history over the course of time is important for investors
interested in comparing AYTU's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AYTU versus a peer is one thing; comparing
AYTU market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AYTU can fluctuate over the course of history.
With this page we aim to empower investors researching AYTU by allowing them to research the AYTU market cap history. |
Free AYTU Email Alerts:
Video: The Importance of Market Cap
